MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment

Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders

(2017) Cécile Pagan et al.   Scientific Reports

Circulating Plasma Micro RNAs in Patients with Major Depressive Disorder Treated with Antidepressants: A Pilot Study

(2016) Virgil Radu Enatescu et al.   Psychiatry Investigation

Comparison of plasma MicroRNA levels in drug naive, first episode depressed patients and healthy controls

(2015) Mehmet Akif Camkurt et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The responsiveness of the different versions of the Hamilton Depression Scale

(2015) Per Bech   World Psychiatry

Identification of Differential MicroRNAs in Cerebrospinal Fluid and Serum of Patients with Major Depressive Disorder

(2015) Yunqiang Wan et al.   PLoS One

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature

(2014) I Fukumoto et al.   BRITISH JOURNAL OF CANCER

7-Chlorokynurenic acid (7-CTKA) produces rapid antidepressant-like effects: through regulating hippocampal microRNA expressions involved in TrkB-ERK/Akt signaling pathways in mice exposed to chronic unpredictable mild stress

(2014) Bin-Bin Liu et al.   PSYCHOPHARMACOLOGY

Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders

(2014) M T Ray et al.   Translational Psychiatry

The Epidemiology of Depression Across Cultures

(2013) Ronald C. Kessler et al.   Annual Review of Public Health

Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants

(2013) K Oved et al.   Translational Psychiatry

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1

(2012) Laisheng Li et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Blood microRNA changes in depressed patients during antidepressant treatment

(2012) Luisella Bocchio-Chiavetto et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Depression: an inflammatory illness?: Figure 1

(2012) Rajeev Krishnadas et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

MicroRNA Regulation of the Synaptic Plasticity-Related Gene Arc

(2012) Karin Wibrand et al.   PLoS One

Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder

(2012) Reiji Yoshimura et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Evidence demonstrating role of microRNAs in the etiopathology of major depression

(2011) Yogesh Dwivedi   JOURNAL OF CHEMICAL NEUROANATOMY

MicroRNA dysregulation in schizophrenia

(2011) Natalie J. Beveridge et al.   NEUROBIOLOGY OF DISEASE

MicroRNAs and depression

(2011) Sophie Mouillet-Richard et al.   NEUROBIOLOGY OF DISEASE

Brain-derived neurotrophic factor and suicide pathogenesis

(2010) Yogesh Dwivedi   ANNALS OF MEDICINE

Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopramvsparoxetine

(2010) J.P. Boulenger et al.   CURRENT MEDICAL RESEARCH AND OPINION

Association between depression severity and neurocognitive function in major depressive disorder: A review and synthesis.

(2010) Shawn M. McClintock et al.   NEUROPSYCHOLOGY

Does early improvement in major depression protect against treatment emergent suicidal ideation?

(2009) Florian Seemüller et al.   JOURNAL OF AFFECTIVE DISORDERS

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

(2008) Wayne C. Drevets et al.   Brain Structure & Function

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

The molecular neurobiology of depression

(2008) Vaishnav Krishnan et al.   NATURE

Major Depressive Disorder

(2008) R.H. Belmaker et al.   NEW ENGLAND JOURNAL OF MEDICINE